继伊马替尼、舒尼替尼和瑞非尼之后治疗gist的新分子靶向药物:叙述性综述

{"title":"继伊马替尼、舒尼替尼和瑞非尼之后治疗gist的新分子靶向药物:叙述性综述","authors":"A. Mazzocca, A. Minelli, Flavia Paternostro, M. Silletta, A. Napolitano, B. Vincenzi","doi":"10.21037/gist-21-6","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":93755,"journal":{"name":"Gastrointestinal stromal tumor","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"New molecularly targeted drugs for gist after imatinib, sunitinib and regorafenib: a narrative review\",\"authors\":\"A. Mazzocca, A. Minelli, Flavia Paternostro, M. Silletta, A. Napolitano, B. Vincenzi\",\"doi\":\"10.21037/gist-21-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":93755,\"journal\":{\"name\":\"Gastrointestinal stromal tumor\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gastrointestinal stromal tumor\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21037/gist-21-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastrointestinal stromal tumor","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/gist-21-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}